SEARCH

SEARCH BY CITATION

References

  • BARRETT-CONNOR, E. & KRITZ-SILVERSTEIN, D. (1996). Dose hyperinsulinemia preserve bone Diabetes Care, 19, 13881392.
  • CLARK, J.B., PALMER, C.J. & SHAW, W.N. (1983). The diabetic Zucker fatty rat (41611). Proc. Soc. Exp. Biol. Med., 173, 6875.
  • CORNISH, J., CALLON, K.E. & REID, I.R. (1996). Insulin increases histomorphometric indices of bone formation in vivo. Calcif. Tissue Int., 59, 492495.
  • DANIS, R.P. & YANG, Y. (1993). Microvascular retinopathy in the Zucker diabetic fatty rat. Invest. Ophthalmol. Vis. Sci., 34, 23672371.
  • DESVERGNE, B., IJPENBERG, A., DEVCHAND, P.R. & WAHLI, W. (1998). The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signalling. J. Steroid. Biochem. Molec. Biol., 65, 6574.
  • FUKUNAGA, Y., MINAMIKAWA, J., INOUE, D. & KOSHIYAMA, H. (1997). Dose insulin use increase bone mineral density in patients with non-insulin-dependent diabetes mellitus Arch. Intern. Med., 157, 26682669.
  • HANSSEN, K.F. (1991). The determinants of microvascular complications in diabetes: an overview. In Textbook of Diabetes. ed Pickup, J.C. and Williams, G. pp. 519525 Oxford: Blackwell Scientific Publications.
  • HANSSEN, K.F. (1997). Blood glucose control and microvascular and macrovascular complications in diabetes. Diabetes, 46, (Suppl. 2)S101S103.
  • HOTTA, N., NAKAMURA, J., KAKUTA, H., FUKASAWA, H., KOH, N., SAKAKIBARA, F., MORI, K. & SAKAMOTO, N. (1995). Niceritrol prevents the decrease in red blood cell 2,3-diphosphoglycerate and neuropathy in streptozotocin-induced diabetic rats. J. Diab. Comp., 9, 133139.
  • HUI, S.L., EPSTEIN, S. & JOHNSTON, C.C. (1985). A prospective study of bone mass in patients with Type 1 diabetes. J. Clin. Endocrinol. Metab., 60, 7480.
  • ISHIDA, H., SEINO, Y., MATSUKURA, S., IKEDA, M., YAWATA, M., YAMASHITA, G., ISHIZUKA, S. & IMURA, H. (1985). Diabetic osteopenia and circulating levels of vitamin D metabolites in type 2 (noninsulin-dependent) diabetes. Metabolism, 34, 797801.
  • ITUARTE, E.A., HALSTEAD, L.R., IIDA-KLEIN, A., ITUARTE, H.G. & HAHN, T.J. (1989). Glucose transport system in UMR-106-01 osteoblastic osteosarcoma cells: regulation by insulin. Calcif. Tissue Int., 45, 2733.
  • JOHNSTON, C.C., HUI, S.L. & LONGCOPE, C. (1985). Bone mass and sex steroid concentrations in postmenopausal caucasian diabetes. Metabolism, 34, 544550.
  • KELLER, H., DREYER, C., MEDIN, J., MAHFOUDI, A., OZATO, K. & WAHLI, W. (1993). Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc. Natl.Acad. Sci. U.S.A., 90, 21602164.
  • KLEIN, R. (1995). Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care, 18, 258268.
  • LEIVIN, M.E., BOISSEAU, V.C. & AVIOLI, L.V. (1976). Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. N. Engl. J. Med., 294, 241245.
  • MAEGAWA, H., OBATA, T., SHIBATA, T., FUJITA, T., UGI, S., MORINO, K., NISHIO, Y., KOJIMA, H., HIDAKA, H., HANEDA, M., YASUDA, H., KIKKAWA, R. & KASHIWAGI, A. (1999). A new antidiabetic agent (JTT-501) rapidly stimulates glucose disposal rates by enhancing insulin signal transduction in skeleral muscle. Diabetologia, 42, 151159.
  • MIYOSHI, T. & GOTO, I. (1973). Serial in vivo determinations of nerve conduction velocity in rat tails: physiological and pathological changes. Electroencephalogr. Clin. Neurophysiol., 35, 125131.
  • OHKUBO, Y., KISHIKAWA, H., ARAKI, E., MIYATA, T., ISAMI, S., MOTOYOSHI, S., KOJIMA, Y., FURUYOSHI, N. & SHICHIRI, M. (1995). Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res. Clin. Prac., 28, 103117.
  • OHNEDA, M., INMAN, L.R. & UNGER, R.H. (1995). Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT 2 and glucose incompetence. Diabetologia, 38, 173179.
  • OKUNO, Y., NISHIZAWA, Y., SEKITA, K., HAGIWARA, S., MIKI, T. & MORII, H. (1991). Total and regional bone mineral content in patients with non-insulin dependent diabetes mellitus. J. Nutr. Sci. Vitaminol., 37, S43S49.
  • PETERSON, R.G., NEEL, M.A., LITTLE, L.A., KINCAID, J.C. & EICHBERG, J. (1990a). Neuropathic complications in the Zucker diabetic fatty rat (ZDF/Drt-fa). In Frontiers in diabetic research. Lesson from animal diabetes III., ed. Shafrir, E. pp. 456458. London: Smith-Gordon.
  • PETERSON, R.G., SHAW, W.N., NEEL, M.A., LITTLE, L.A. & EICHBERG, J. (1990b). Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus. ILAR News, 32, 1619.
  • PIEPKORN, B., KANN, P., FORST, T., ANDREAS, J., PFÜTZNER, A. & BEYER, J. (1997). Bone mineral density and bone metabolism in diabetes mellitus. Horm. Metab. Res., 29, 584591.
  • REID, I.R., EVANS, M.C., COOPER, G.J.S., AMES, R.W. & STAPLETON, J. (1993). Circulating insulin levels are related to bone density in normal postmenopausal women. Am. J. Physiol., 265, E655E659.
  • SALTIEL, A.R. & OLEFSKY, J.M. (1996). Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes, 45, 16611669.
  • SHIBATA, T., MATSUI, K., NAGAO, K., SHINKAI, H., YONEMORI, F. & WAKITANI, K. (1999). Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative. Eur. J. Pharmacol., 364, 221219.
  • SHIBATA, T., MATSUI, K., YONEMORI, F. & WAKITANI, K. (1998). JTT-501, a novel antidiabetic agent, improves insulin resistance in genetic and non-genetic insulin-resistant models. Br. J. Pharmacol., 125, 17441750.
  • SLIEKER, L.J., SUNDELL, K.L., HEATH, W.F., OSBORNE, E., BUE, J., MANETTA, J. & SPORTSMAN, J.R. (1992). Glucose transporter levels in tissues of spontaneously diabetic Zucker fa/fa rat (ZDF/drt) and viable yellow mouse (Avy/a). Diabetes, 41, 187193.
  • STURIS, J., PUGH, W.L., TANG, J. & POLONSKY, K.S. (1995). Prevention of diabetes does not completely prevent insulin secretory defects in the ZDF rat. Am. J. Physiol., 269, E786E792.
  • TERASAKI, J., ANAI, M., FUNAKI, M., SHIBATA, T., INUKAI, K., OGIHARA, T., ISHIHARA, H., KATAGIRI, H., ONISHI, Y., SAKODA, H., FUKUSHIMA, Y., YAZAKI, Y., KIKUCHI, M., OKA, Y. & ASANO, T. (1998). Role of JTT-501, a new insulin sensitiser, in restoring impaired GLUT4 translocation in adipocytes of rats fed a high fat diet. Diabetologia, 41, 400409.
  • THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med., 329, 977986.
  • THOMAS, D.M., UDAGAWA, N., HARDS, D.K., QUINN, J.M.W., MOSELEY, J.M., FINDLAY, D.M. & BEST, J.D. (1998). Insulin receptor expression in primary and cultured osteoclast-like cells. Bone, 23, 181186.
  • TOKUYAMA, Y., STURIS, J., DEPAOLI, A.M., TAKEDA, J., STOFFEL, M., TANG, J., SUN, X., POLONSKY, K.S. & BELL, G.I. (1995). Evolution of β-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes, 44, 14471457.
  • UK PROSPECTIVE DIABETES STUDY GROUP. (1998a). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352, 837853.
  • UK PROSPECTIVE DIABETES STUDY GROUP. (1998b). Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet, 352, 854865.
  • UNGER, R.H. (1991). Role of impaired glucose transport by β cells in the pathogenesis of diabetes. J. NIH Res., 3, 7780.
  • VAN DAELE, P.L.A., STOLK, R.P., BURGER, H., ALGRA, D., GROBBEE, D.E. HOFMAN, A., BIRKENHÄGER, J.C. & POLS, H.A.P. (1995). Bone density in non-insulin-dependent diabetes mellitus.: The Rotterdam Study. Ann. Intern. Med., 122, 409414.
  • WAKASUGI, M., WAKAO, R., TAWATA, M., GAN, N., KOIZUMI, K. & ONAYA, T. (1993). Bone mineral density measured by dual energy xray absorptiometry in patients with non-insulin-dependent diabetes mellitus. Bone, 14, 2933.
  • WEINSTOCK, R.S., GOLAND, R.S., SHANE, E., CLEMENS, T.L., LINDSAY, R. & BILEZIKIAN, J.P. (1989). Bone mineral density in women with type II diabetes mellitus. J. Bone Miner. Res., 4, 97101.
  • WISKE, P.S., WENTWORTH, S.M., NORTON, J.A., EPSTEIN, S. & JOHNSTON, C.C. (1982). Evaluation of bone mass and growth in young diabetes. Metabolism, 31, 848854.